Summary The Chart of the Day belongs to biotechnology company Verona Pharma (VRNA) . I found the stock by using Barchart's ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into ...

Albany Medical Center’s adult Cystic Fibrosis Care Center has been treating patients aged 18 and older living with cystic fibrosis (CF).

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...

Adults with cystic fibrosis experience higher pain prevalence and severity compared to healthy controls, with significant unmet needs in pain management. New study highlights critical gaps in care.

Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...

Ann & Robert H. Lurie Children’s Hospital of Chicago launched a newborn screening awareness campaign, with signage on public transit and billboards across Chicago urging parents to contact their child ...

Receiving a diagnosis for any disease/condition is not an easy experience. One organization hopes to make patients newly ...

Fund provides air purifiers & supplies to cystic fibrosis community impacted by wildfiresLos Angeles, CA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...